Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, announced data underscoring the clinical impact of mNGS using Delve Detect to identify ...
The Intersection of AI and Biology in Revolutionizing Healthcare In recent years, the fusion of artificial intelligence (AI) with biological ...
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma Human epidermal growth factor 2 (HER2/ERBB2) has ...
Key growth drivers include technological advancements, reduced sequencing costs, and increased interest from academia and pharmaceuticalsDublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Single Cell ...
Integrating metagenomics and bioinformatics enhances food safety, enabling early detection of microbial risks and supporting ...
Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting System ClinBioNGS is a modular, fully containerized ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results